Clinical Trials Directory

Trials / Completed

CompletedNCT02025361

Impact of Local Anesthesia Type on Cancer Detection Rate in Transrectal Ultrasound Guided Prostate Biopsy

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
422 (actual)
Sponsor
Bagcilar Training and Research Hospital · Other Government
Sex
Male
Age
Healthy volunteers
Not accepted

Summary

Transrectal ultrasound guided prostate biopsy (TRUS-Bx) is the gold standard method for prostat cancer diagnosis. Cancer detection rate is an important issue in TRUS-Bx. Effective biopsy protocol is necessary to enhance cancer detection rate during the procedure. Patient tolerance may improve the protocol effectiveness and quality. Adequate patient tolerance with optimal local anesthesia may enhance cancer detection rate in TRUS-Bx.

Detailed description

In transrectal ultrasound guided prostate biopsy ultrasound's probe manipulation is necessary for effective biopsy. Patient discomfort and pain frequently occurs with manipulation of probe during transrectal ultrasound guided prostate biopsy and this situation may qualify of the achievement of this procedure. In this study, we aimed to describe the impact of different two local anesthesia types on cancer detection rate in transrectal ultrasound guided prostate biopsy.

Conditions

Interventions

TypeNameDescription
DRUGintrarectal lidocaine gelintrarectal local anesthetic application
DRUGperiprostatic nerve blockadeperiprostatic local anesthetic application

Timeline

Start date
2009-02-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2014-01-01
Last updated
2018-01-18

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02025361. Inclusion in this directory is not an endorsement.